Author:
Mansuy Marion,Nikkels-Tassoudji Nazli,Arrese Jorge E.,Rorive Andree,Nikkels Arjen F.
Publisher
Springer Science and Business Media LLC
Reference11 articles.
1. Lebwohl M, Shumack S, Stein Gold L, et al. Long-term follow-up study of ingenol mebutate gel for the treatment of actinic keratoses. JAMA Dermatol. 2013; 149:666–70.
2. Keating GM. Ingenol mebutate gel 0.015% and 0.05%: in actinic keratosis. Drugs. 2012;72:2397–405.
3. Ersvaer E, Olsnes Kittang A, Hampson P, et al. The protein kinase C agonist PEP005 (Ingenol 3-Angelate) in the treatment of human cancer: a balance between efficacy and toxicity. Toxins. 2010; 2:174-94.
4. Stahlhut M, Bertelsen M, Hoyer-Hansen M, et al. Ingenol mebutate: induced cell death patterns in normal and cancer epithelial cells. J Drugs Dermatol. 2012;11:1181–92.
5. Cozzi SJ, Le TT, Ogbourne SM, James C, Suhrbier A. Effective treatment of squamous cell carcinomas with ingenol mebutate gel in immunologically intact SKH1 mice. Arch Dermatol Res. 2013;305:79–83.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献